Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2024

Health Catalyst reports solid Q1 earnings, eyes tech-enabled services growth

Health Catalyst's Q1 2023 earnings call highlighted strong financial performance, emphasizing growth in total revenue and technology revenue. The company's focus on client improvements, scalability, and offshore resources presents opportunities for expansion. However, challenges related to labor costs and the complexities of expanding tech-enabled managed services were also addressed.

Health Catalyst exceeds Q2 earnings, secures $110M in contracts

Health Catalyst's Q2 2023 earnings call showcased strong financial performance, exceeding guidance and securing significant contracts. The company's focus on client improvement, growth, and scale, along with long-term strategic relationships, positions it for continued success. However, challenges in margin ramp-up and potential impact on hospitals require careful navigation.

Health Catalyst exceeds Q3 revenue expectations, poised for sustained growth

Health Catalyst's Q3 2023 earnings call showcased robust financial performance, strategic focus on improvement, growth, and scale, and a positive outlook for sustained growth. However, addressing investor concerns and effectively leveraging opportunities will be critical for long-term success and value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

SALT LAKE CITY, April 24, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2024 operating results on Thursday, May 9, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024

Health Catalyst (HCAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -24.71% in 4 Weeks, Here's Why You Should You Buy the Dip in Health Catalyst (HCAT)

The mean of analysts' price targets for Health Catalyst (HCAT) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts Think Health Catalyst (HCAT) Could Surge 53.65%: Read This Before Placing a Bet

Inspire Medical Systems Inc

Talkspace

A few Zacks Medical Info Systems industry stocks like Inspire Medical Systems (INSP), Talkspace (TALK) and Health Catalyst (HCAT) are expected to gain from the new normal trends.

3 Medical Info Systems Stocks to Buy as Industry Improves

Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offering and next-gen data platform, are expected to drive growth and margin expansion. HCAT's long-term guidance of exceeding $100 million in EBITDA by FY28 is achievable, and its valuation should improve as it demonstrates execution and margin expansion.

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

SALT LAKE CITY , Feb. 27, 2024 /PRNewswire/ -- Today, Health Catalyst announced the winner of the 2024 Flywheel Award. The award recognizes healthcare organizations that have showcased outstanding results in measurable, impactful improvements.

Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award

The heavy selling pressure might have exhausted for Health Catalyst (HCAT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

After Plunging -24.47% in 4 Weeks, Here's Why the Trend Might Reverse for Health Catalyst (HCAT)

Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Health Catalyst (HCAT) Q4 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.05 per share a year ago.

Health Catalyst (HCAT) Q4 Earnings and Revenues Beat Estimates

SOUTH JORDAN, Utah., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2023.

Health Catalyst Reports Fourth Quarter and Year End 2023 Results

SALT LAKE CITY , Feb. 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that the Able Health Registry has received Quality Payment Program (QPP) Qualified Registry approval for the 2024 performance year by the Centers for Medicare and Medicaid Services (CMS). According to CMS, the QPP program "aims to improve the quality and safety of care for all individuals and to reduce the administrative burden on clinicians, allowing more time to focus on person-centered care and improving health outcomes.

Health Catalyst's Able Health Registry Receives CMS's QPP Qualified Registry Approval for 2024

SALT LAKE CITY , Feb. 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced MeasureAble™ has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT certification via Drummond Group LLC, an Authorized Certification Body (ACB). This approval designates that eligible providers and hospitals may use MeasureAble to meet requirements for various quality reporting programs that involve the use of certified electronic health records (EHR) technology to calculate and report quality measures.

Health Catalyst's MeasureAble™ Earns ONC Health IT Certification

Beyond analysts' top -and-bottom-line estimates for Health Catalyst (HCAT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Health Catalyst (HCAT) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

SALT LAKE CITY, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2023 operating results on Thursday, February 22, 2024, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Fourth Quarter and Full Year 2023 Operating Results and Host Conference Call on Thursday, February 22, 2024

SALT LAKE CITY , Feb. 7, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that VitalCDM, Vitalware by Health Catalyst's flagship hospital chargemaster solution, ranked number one in the Revenue Cycle - Chargemaster Management category of the "2024 Best in KLAS: Software & Services."  "Each day, our team members dedicate themselves to delivering world-class service and product excellence in support of our clients and their financial and regulatory needs.

Vitalware by Health Catalyst Earns Best in KLAS Achievement in Chargemaster Management

The consensus price target hints at a 29% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Wall Street Analysts Believe Health Catalyst (HCAT) Could Rally 28.97%: Here's is How to Trade

SALT LAKE CITY , Jan. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a multi-year partnership with SacValley MedShare (SacValley), one of California's largest and most established qualified health information organization (QHIO). Together with its regional partners, SacValley works to improve the quality and safety of healthcare by sharing health information securely and efficiently between all providers, facilities, and patients.

SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO)

SALT LAKE CITY, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco. In conjunction, there will be a presentation on Wednesday, January 10, 2024 at 1:30pm PT. The replay of the presentation will be available online at https://ir.healthcatalyst.com.

Health Catalyst to Participate in Upcoming Investor Conference

SALT LAKE CITY , Nov. 29, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced WakeMed Health & Hospitals ("WakeMed") has achieved $10M variable cost reduction by decreasing unnecessary care variation while helping to improve care quality. Unwarranted clinical variations are inconsistencies in care practices that can sometimes negatively affect patient outcomes and organizational performance and are a main driver of excess costs in healthcare.

Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation

SALT LAKE CITY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the following upcoming investor conferences:

Health Catalyst to Participate in Upcoming Investor Conferences

Health Catalyst, Inc. (NASDAQ:HCAT ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Adam Brown - Senior Vice President of FP&A & Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Participants Vishal Patel - Piper Sandler Daniel Grosslight - Citi Sameer Patel - Evercore ISI Jenny Shen - BTIG Scott Schoenhaus - KeyBanc Stan Berenshteyn - Wells Fargo Sarah James - Cantor Fitzgerald Operator Welcome to the Health Catalyst Third Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for your questions following the presentation.

Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript

BOSTON--(BUSINESS WIRE)--Electronic Registry Systems (ERS) acquired by Health Catalyst; Outcome Capital served as the exclusive strategic and financial advisor to ERS.

Outcome Capital Announces Electronic Registry Systems (ERS) Acquisition by Health Catalyst

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Compared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key Metrics

SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2023.

News for Health Catalyst Inc Stock (HCAT)